SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000891618-02-002437
Filing Date
2002-05-15
Accepted
2002-05-15 12:51:24
Documents
3
Period of Report
2002-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f81466e10-q.htm 10-Q 183709
3 EXHIBIT 10.7.4 f81466ex10-7_4.txt EX-10.7.4 20612
4 EXHIBIT 10.12.1 f81466ex10-12_1.txt EX-10.12.1 3292
  Complete submission text file 0000891618-02-002437.txt   209335
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22570 | Film No.: 02649974
SIC: 2833 Medicinal Chemicals & Botanical Products